Come up with a name for your new list and we'll add to it:
American Gene Technologies International raised a round of funding on February 20, 2018. Investors include
Alumni Ventures Group.
American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).…